[Cetiedil and the uterine musculature].
作者信息
Lampa E, Magliulo S, Alise G, Spaziante G, Golino P, Di Tonto B
出版信息
Arch Ostet Ginecol. 1978 Mar-Apr;83(3-4):127-38.
PMID:44468
Abstract
摘要
相似文献
1
[Cetiedil and the uterine musculature].[西替地尔与子宫肌层]
Arch Ostet Ginecol. 1978 Mar-Apr;83(3-4):127-38.
2
[Pharmacological considerations on cetiedil, a drug with prevalent hemodynamic activity].关于塞替地尔（一种具有显著血流动力学活性的药物）的药理学考量
Clin Ter. 1979 Jul 15;90(1):11-45.
3
4
Evaluation of tocolytic efficacy of selective beta2 adrenoceptor agonists on buffalo uterus.选择性β2肾上腺素能受体激动剂对水牛子宫的宫缩抑制疗效评估。
Indian J Exp Biol. 2004 Sep;42(9):913-8.
5
Beta 2-agonist treatment enhances uterine oxytocin receptor mRNA expression in pregnant rats.β2 激动剂治疗可增强妊娠大鼠子宫中催产素受体 mRNA 的表达。
Mol Reprod Dev. 2004 Sep;69(1):60-5. doi: 10.1002/mrd.20158.
6
Pharmacological findings on cetiedil.
Arzneimittelforschung. 1978;28(12):2222-8.
7
Pharmacologic inhibition of uterine contractility.子宫收缩力的药理学抑制
Mead Johnson Symp Perinat Dev Med. 1980(15):26-36.
8
[Clinical pharmacology in obstetrics: regulation of the uterus].[产科临床药理学：子宫的调节]
Med Klin. 1975 May 2;70(18):798-805.
9
A comparative study between the cardiovascular effects of cetiedil, a new vasodilator, and papaverine and aminophylline.
J Pharmacol Exp Ther. 1976 Jul;198(1):176-86.
10
[Effects of verapamil and gynipral on the uterine contractile activity in rats].[维拉帕米和绞股蓝总苷对大鼠子宫收缩活动的影响]
Eksp Klin Farmakol. 2000 Nov-Dec;63(6):28-9.
Zotero 插件